Sellas Life Sciences
SLS
$1.35
Share price
5.47%
Change (1 day)
-8.16%
Change (1 year)
Categories
Sellas Life Sciences (SLS) - P/B ratio
P/B ratio as of May 2024 : -9.52
According to Sellas Life Sciences's latest financial reports the company has a price-to-book ratio of -9.52.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Sellas Life Sciences - P/B ratio (from 2008 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -4.26 | -142.54% |
| 2022-12-31 | 10.0 | 131.99% |
| 2021-12-31 | 4.32 | 46.38% |
| 2020-12-31 | 2.95 | -17.73% |
| 2019-12-31 | 3.59 | -30.59% |
| 2018-12-31 | 5.17 | -76.41% |
| 2017-12-31 | 21.9 | -619.86% |
| 2016-12-31 | -4.21 | -123.92% |
| 2015-12-31 | 17.6 | 233.87% |
| 2014-12-31 | 5.27 | -94.28% |
| 2013-12-31 | 92.2 | 1917.09% |
| 2012-12-31 | 4.57 | 129.4% |
| 2011-12-31 | 1.99 | -89.78% |
| 2010-12-31 | 19.5 | -80.53% |
| 2009-12-31 | 100 | 1036.59% |
| 2008-12-31 | 8.81 | |
| 2007-12-31 | N/A | |
| 2006-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | -130.08% | 🇺🇸 USA |